Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Objective: To study the profile and the therapeutic response of patients with laryngopharyngeal reflux (LPR) at the hypopharyngeal-esophageal multichannel intraluminal impedance-pH monitoring (HEMII-pH) according to the initial pepsin saliva concentration.
Methods: From January 2018 to January 2020, patients with positive LPR diagnosis at the HEMII-pH were consecutively recruited from 3 European Hospitals. Saliva pepsin concentration (Peptest™) was measured during the HEMII-pH testing period and patients were classified into 2 groups: negative versus positive Peptest. The clinical outcomes, that is, gastrointestinal and HEMII-pH findings, reflux symptom score-12 (RSS-12), and 3-month therapeutic response, were compared between groups.
Results: A total of 124 patients completed the study. Among them, 30 patients had negative Peptest. Pharyngeal reflux events occurred outside 1-hour post-meal time in 74.0%, after the meals in 20.5% and nighttime in 5.5%. The pepsin saliva level was not significantly associated with the reflux events preceding the sample collection. Patients with positive Peptest had better improvement of RSS-12 digestive and respiratory subscores and oral, pharyngeal, and laryngeal findings compared with patients with negative Peptest.
Conclusion: Patients with high saliva pepsin concentration had no stronger gastrointestinal, HEMII-pH, or clinical outcomes compared with those with low or undetectable saliva pepsin concentration.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1177/0003489420986347 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Salivary Pepsin Measurement in Laryngopharyngeal Reflux Disease: A Systematic Review of Diagnostic Accuracy and Performance.
J Voice
August 2025
Department of Surgery, Research Institute for Language Science and Technology, University of Mons (UMons), Mons, Belgium; Department of Otolaryngology Head Neck Surgery, CHU Saint-Pierre, Brussels, Belgium; Department of Otolaryngology-Head & Neck Surgery, Foch Hospital, School of Medicine, UFR Simo
Objective: To analyze the methods used for digestive enzyme measurements in saliva of patients with laryngopharyngeal reflux disease (LPRD) and to investigate their respective diagnostic performances.
Methods: Three independent investigators conducted a PubMED, Scopus, and Cochrane Library database search for studies investigating the digestive saliva enzyme measurements in LPRD patients according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statements.
Results: Of the 183 screened studies, 38 studies met the inclusion criteria (1461 females (47.
The Trajectory of Reflux and its Associating Factors in Patients After Esophagectomy Based on Salivary Pepsin-Testing: A Prospective Longitudinal Study.
Ann Surg Oncol
August 2025
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Peking, China.
Background: Post-esophagectomy reflux remains a significant clinical challenge. This study pioneered the use of salivary pepsin-testing (SPT) as an objective biomarker to explore the reflux, addressing limitations of subjective symptom scoring in esophagectomy outcomes research.
Methods: Consecutive patients (age 18-75 years) with histologically confirmed esophageal carcinoma who underwent esophagectomy were prospectively enrolled to explore the trajectory and associating factors of reflux after surgery.
Accuracy and Clinical Findings of Saliva Digestive Biomarkers in Laryngopharyngeal Reflux Disease.
Laryngoscope
August 2025
LHUB, CHU Saint-Pierre, Brussels, Belgium.
Objective: To evaluate the diagnostic performance of multiple digestive enzyme biomarkers in detecting and characterizing laryngopharyngeal reflux disease (LPRD).
Methods: Patients with LPRD at the 24-h hypopharyngeal-esophageal multichannel intraluminal impedance-pH testing (HEMII-pH) were consecutively recruited from January 2020 to May 2024 from two European hospitals. The control group consisted of adults without symptoms.
Diagnostic value of Peptest™ combined with gastroesophageal reflux disease questionnaire in identifying patients with gastroesophageal reflux-induced chronic cough.
Chron Respir Dis
August 2025
Department of Pulmonary and Critical Care Medicine, Tongji Hospital, School of Medicine, Tongji University, Shanghai, China.
ObjectivesGastroesophageal reflux-related chronic cough (GERC), an extraesophageal manifestation of gastroesophageal reflux disease (GERD). Although 24h MII-pH monitoring is the gold standard for diagnosing GERC, its invasiveness, high cost, and limited accessibility hinder widespread use in many clinical settings. This study aimed to develop a non-invasive machine learning model incorporating Peptest™ and GerdQ scores to facilitate GERC detection, particularly in primary care and resource-limited environments where MII-pH testing is not readily available.
View Article and Find Full Text PDFDiagnostic value of fasting hypopharyngeal salivary pepsin concentration test for laryngopharyngeal reflux disease.
World J Otorhinolaryngol Head Neck Surg
June 2025
Otolaryngology, Head and Neck Surgery Department of Fujian Provincial Hospital Provincial Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital Fuzhou Fujian China.
Objective: To investigate the diagnostic value of the fasting hypopharyngeal salivary pepsin concentration test for laryngopharyngeal reflux disease (LPRD).
Methods: Volunteers were grouped by reflux symptom index scale, reflux finding score scale, and 24-h hypopharyngeal-esophageal multichannel intraluminal impedance with pH monitoring results. The study comprised 56, 27, and 20 individuals in the LPRD, asymptomatic laryngopharyngeal reflux (LPR), and asymptomatic non-LPR groups, respectively.